Rezultati pretraživanja
  1. 27. kol 2019.

    The ’s Priority Review Voucher is a great way to expedite the approval of a new drug or biologic, with a decision made in 6 months!

  2. 21. kol 2019.

    INmune Bio - Week 3: Operations Tour at UCL with Dr. Mark Lowdell --- Part 3/4 of the Campaign --

    Prikaži ovu nit
  3. 13. ruj 2019.

    INmune Bio - Week 4: Interview with CEO - RJ Tesi, CFO - David Moss and Assoc. General Counsel - Joshua --- Part 4/4 of the Campaign --

  4. prije 7 sati
  5. 10. lis 2019.

    🔊ZYMVOL awarded with SME Phase II from European Commission! Check the document for more info 👉 Want to know more? Contact us!

  6. This is our third video in the series about the biomedical video production process. Watch behind-the-scenes of 3D Modeling and Animation!

  7. 9. kol 2019.
  8. 27. lip 2019.

    A warm (and very sunny) welcome to our marvellous summer interns - Erin, Kristin, Simran & Kimberley. Great to have you on the team!

  9. 19. kol 2019.

    Excited to be going to the 2019 Next GenerationDx Summit in Washington, DC. If you're there too, DM Colin Coros to chat about EVs, diagnostics, and !

  10. 8. kol 2019.
  11. 23. srp 2019.

    An opportunity for Malaysian undergraduates to learn about biotechnology business consultancy field Consulting Sdn. Bhd.

  12. 13. kol 2019.

    One-quarter of all the biotechnology companies in Spain are based in Madrid and their turnover accounts for more than 60% of Spain.

  13. Currently looking for Angel Investors or VC firms that are interested in fund raising $1 million for an early stage Biotechnology startup. We'll use modified natural killer cells with genome mapping of all 4 types of Leukemia to develop a cure.

  14. 10. ruj 2019.

    We're speaking and exhibiting at the PHSS Annual Conference 2019 in Kensington, London today.  Rene Friedrichs will be holding a presentation on The Contamination of Biologics and ATMPs at 10.     

  15. 1. tra 2019.
  16. 8. kol 2019.

    is often a challenge in the , but Chipscreen had no such issues, with shares for their IPO being 3000Xs oversubscribed on China’s new tech board! How did this happen? Why did it happen? Most importantly, can we make it happen here in ?

  17. 22. kol 2019.

    We recently reached 100+ followers! Thank you all for your support over the years! We would like to find out what you would like to see more of. Please leave your feedback in the comments below. ; ; ; ; ;

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.